News
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
SAN ANTONIO, July 09, 2025--bioAffinity Technologies' CyPath® Lung detects Stage 1A lung cancer when imaging was inconclusive ...
Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...
From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...
This newly launched program can save lives, with the proportion of cases identified at an early stage expected to rise from ...
During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient ...
New guidelines confirm that for biomarker testing, navigation‑guided bronchoscopy yields lung tissue equal to that from ...
I was diagnosed with breast cancer, then lung cancer 17 years later — and both ultimately led me to make meaningful, positive ...
6d
Daily Express US on MSNThe alarming rise in lung cancer in non-smokers and why, according to expertsLung cancer isn't just a smoker's disease. Discover the surprising truth about who else is at risk and why the numbers are rising in unexpected groups.
16d
Bangkok Post on MSNScreening a deadly diseaseWhen celebrated actor, Natthawut "Poh" Skidjai, revealed on his YouTube channel @PohSakidAey that his wife Aey Pornthip had been diagnosed with stage one lung cancer after an annual health checkup, ...
4d
News-Medical.Net on MSNNew nanobody-liposome combo stops lung cancer growth and delivers targeted chemotherapyResearchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results